This brochure provides a comprehensive overview of Ace Therapeutics' cutting-edge technologies and one-stop preclinical research services in the field of stroke. Through an integrated multi-platform approach, Ace Therapeutics is committed to delivering efficient and customized solutions to accelerate the development of innovative stroke therapies.
Download our brochure to explore how our solutions can accelerate your stroke research and help you develop innovative therapies.
Our Capabilities
Advanced Technology Platform
Ace Therapeutics provides customized stroke models and technology platforms to support preclinical stroke research.
Our customized in vitro models of stroke and advanced cell-based assay platform accelerate the discovery of novel stroke therapies.
The intraluminal filament tMCAO is a widely used experimental model to mimic focal cerebral ischemia followed by reperfusion, studying disease mechanisms and treatments.
Photochemical thrombosis is a method for the induction of ischemic stroke in the cerebral cortex, which aids in stroke mechanism and therapy development.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.